Immunotherapy and Gene Therapy for Mesothelioma Treatment

The Penn Mesothelioma and Pleural Program is a center made up experts from different fields who are dedicated to uncovering new cancer treatments for cancer treatments for patients with pleural mesothelioma and other pleural diseases.

Improving Mesothelioma Survival with Innovation

In addition to offering the best treatments available today, through in-house and collaborative research, Penn Medicine develops the best new treatments for mesothelioma. Biological therapies, (also referred to as immunotherapy, biological response modifier therapy, or biotherapy) are among the most innovative mesothelioma treatments available in the world.

Biological therapy for mesothelioma is designed to use the body's immune system to actually fight cancerous cells so the body can heal itself. Penn's medical oncologists use biologic or synthetic agents to repair stimulate or enhance the immune system, triggering the body's natural defenses to eliminate the cancer cells.

Gene Therapy for Mesothelioma

Researchers at Penn are pioneering the use of two forms of gene therapy to treat mesothelioma. In the first approach, a new gene is placed in a modified cold virus and inserted into the tumor itself. This new gene makes a substance called interferon that causes the body to reject the tumor using its own immune system.

In the second approach, patients' own white blood cells are collected and modified to recognize the tumor. When injected back into the patient, they attack and kill the tumor.

Need More Information on Mesothelioma Immunotherapy?

Contact the Penn Mesothelioma program today. A Nurse/Patient Navigator can help you understand when immunotherapy is appropriate for mesothelioma, as well as all the other available treatment options.

Contact a mesothelioma Nurse/Patient Navigator at Penn today. Call 215-662-9697